27 Results (0 seconds)

Status: Awarded
Published Date: 09/08/2023
Closing Date: 09/08/2023
Value: £21,780
Supply of full Texa Diagnostic unit (x2) - Supply of full Texa Diagnostic unit (x2) to fleet services

Status: Withdrawn
Published Date: 24/03/2022
Closing Date: 06/04/2021
Value: £8,004,000,000
Lateral Flow - Dynamic Purchasing System (DPS) - DHSC intends to establish the DPS to help fulfil its requirement for the ongoing supply of additional Lateral Flow Testing Kits. DHSC is therefore seeking applications from potential providers to be admitted to the DPS. DHSC envisages that the DPS will be divided into the categories of products (Lots) with differential characteristics (more fully described in the Specification). DHSC currently intends to run multiple procurements within the DPS to seek tenders from those providers that have qualified onto the DPS and whose tests fall within one or more of the relevant lots. Whilst the initial response date for applications to join is the 07/04/2021, potential providers may join the DPS at any time up to the date the DPS expires so long as the potential provider meets the criteria stated in the procurement documents found on this Contract Finder Notice as well as on Atamis, the appointed e-sourcing platform (http://health.atamis.co.uk). If a potential provider meets the criteria for admission to the DPS then it may be invited to tender for the award of one or more contracts. DHSC envisages using specific criteria which may, where appropriate, be formulated more precisely in the Invitations to Tender for those procurements. A high-level overview of those criteria is also provided below. For those procurements within the DPS, DHSC envisage using the following criteria which may, where appropriate, be formulated more precisely in the Invitations to Tender for those procurements and may differ depending on Lot and the requirements of the procurement: (A) Cost; (B) Selected elements of the Specification; (C) Performance Requirements; (D) Terms & Conditions; and (E) Social Value. DHSC does not seek to procure Tests which are exclusively nasopharyngeal, oropharyngeal or exclusively both.

Status: Closed
Published Date: 23/03/2022
Closing Date: 29/03/2022
Value: £30,000
CLCH - Lateral Flow Tests - Central London Community Healthcare NHS Trust has a potential upcoming requirement for lateral flow tests, which will be available for staff testing. The trust is defining the requirements, but are interested in receiving pricing and availability from providers. Initially the Trust expects to order 10,000 - 20,000 individual tests, with a preference for these to be provided in smaller pack sizes (for example, 5). These will be delivered to a central location in Parsons Green, London. If of interest, please sent pricing, product details, and availability to edward.dobson@capita.com.

Status: Awarded
Published Date: 19/05/2021
Closing Date: 10/02/2021
Value: £15,000
Supply of DNA Diagnostic COVID-19 Antigen Detection Kit Samples for Phase 3a Validation - Supply of DNA Diagnostic COVID-19 Antigen Detection Kit Samples for Phase 3a Validation

Status: Withdrawn
Published Date: 18/12/2020
Closing Date: 25/11/2020
Value: £911,542,857
Lateral Flow Technology Testing Solutions - Lateral flow tests are used for the rapid (typically 10-30 minutes) detection of a coronavirus antigen. The test strip itself is composed of a nitrocellulose membrane, retained within typically a plastic housing with a window at one end with a sample pad for the addition of the sample and a window at the other end showing a visual positive or negative result dependant on the presence of the virus. The Department of Health & Social Care (DHSC) has a requirement for the provision of a volume order of Lateral flow test across up to a 4 month duration. This procurement process is being conducted using the Open Procedure, in accordance with Regulation 27 of the Public Contracts Regulations 2015. This procurement is using an accelerated timetable in accordance with Regulation 27(5) of the Public Contracts Regulations 2015 due to the current state of urgency faced by the Authority in implementing measures to deal with the Covid-19 pandemic.

Status: Awarded
Published Date: 08/12/2020
Closing Date: 16/11/2020
Value: £16,636
COVID-19 Ag Test - Contract for the supply of Lateral flow kits and consumables, for the Lateral flow test validation

Status: Awarded
Published Date: 08/12/2020
Closing Date: 17/11/2020
Value: £28,050
COVID-19 (SARS CoV-2) Antigen Test Kit - Contract for the supply of Lateral flow kits and consumables, for the Lateral flow test validation

Status: Awarded
Published Date: 07/12/2020
Closing Date: 08/10/2020
Value: £76,050
Oct 20-Mar 21 SARS-CoV-2 positive control supply - Supply for the Turnkey Labs to deliver COVID testing capacity as a dedicated lab in the College of MDS.

Status: Awarded
Published Date: 31/01/2019
Closing Date: 17/08/2018
Value: £150,000
029/2018 Provision of Disposable Reagent Cartridges for an In-Vitro Diagnostic Device - AWARD - Urinary tract infection (UTI) is a common and unpleasant problem affecting thousands of people. It leads to painful symptoms and time off work, and sometimes significant complications, such as kidney damage. GPs diagnose UTI in patients based on their symptoms. Often they will also check a urine sample for infecting bacteria, and for white blood cells, which show the patient's body is generating an inflammatory reaction to the infection. Current methods to look for bacteria and inflammation are slow and sometimes unreliable- it can take three days to get a result for a urine sample sent to a microbiology laboratory. As the patient has ongoing symptoms, the GP will sometimes prescribe antibiotics before the result is back. One fluidic cartridge will be used for each patient test and it will be docked with the instrument when measurement is required. The measurement process for each biomarker involves a magneto-immunoassay. The instrument will perform the following main functions (1) control of sample collection and preparation process, (2) control of magnetic particles to capture the biomarkers, (3) measurement of bound magnetic particles, and (4) the use of an algorithm to convert output of measurement to biomarker concentration. The University now seeks the supply of bespoke cartridges that can be used for testing patient samples. It is expected that the bespoke cartridges will be supplied within 24 months. The key requirements for the cartridge design have already been established at UWE. The cartridge will enable simultaneous measurement of 3 bacteria and one marker of inflammation from a urine sample. It will incorporate storage of the necessary reagents for the assay, so the measurement can take place by simply adding a urine sample (1 and 10mls) to the cartridge.

Status: Awarded
Published Date: 31/01/2019
Closing Date: 17/08/2018
Value: £150,000
028/2018 Diagnostic Instrument for the Detection of UTIs - AWARD - UWE now seeks the supply of a bespoke instrument for detection of Urinary tract infection (UTI) which is a common and unpleasant problem affecting thousands of people. It leads to painful symptoms and time off work, and sometimes significant complications, such as kidney damage. GPs diagnose UTI in patients based on their symptoms. Often they will also check a urine sample for infecting bacteria, and for white blood cells, which show the patient's body is generating an inflammatory reaction to the infection. Current methods to look for bacteria and inflammation are slow and sometimes unreliable- it can take three days to get a result for a urine sample sent to a microbiology laboratory. One fluidic cartridge will be used for each patient test and it will be docked with the instrument when measurement is required. The measurement process for each biomarker involves a magneto-immunoassay. The instrument will perform the following main functions (1) control of sample collection and preparation process, (2) control of magnetic particles to capture the biomarkers, (3) measurement of bound magnetic particles, and (4) the use of an algorithm to convert output of measurement to biomarker concentration.